Prostate Cancer Foundation: 2016 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer

The Prostate Cancer Foundation is accepting applications for investigations of metastatic, lethal prostate cancer. The awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. Teams of three investigators (including one young investigator) are allowed to apply. Award amount is up to $1,000,000 over two years. Application deadline is April 29 by 3:00 p.m.

The Office of Corporate and Foundation Relations has identified the following private funding opportunity: 

Prostate Cancer Foundation: 2016 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer
http://www.pcf.org

The PCF is accepting applications for investigations of metastatic, lethal prostate cancer. The awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. Teams of at least three investigators from non-profit academic research centers, including one young investigator are allowed to apply for this award. The award will go towards supporting large-scale research projects concerning metastatic, lethal prostate cancer for up to two years; the awards will only cover direct research costs and travel to the Annual PCF Scientific Retreat. Preferred research topic areas include:

  • Immunotherapy for the treatment of metastatic, lethal prostate cancer.
  • New systemic treatments for metastatic, lethal prostate cancer including those targeting the currently ‘undruggable.’
  • First-in-field research on new targets for systemic treatment of metastatic, lethal prostate cancer.
  • Mechanisms of resistance to current and investigational drugs targeting the androgen receptor and androgen axis, immune system and chemotherapy.
  • Correlative research around either clinical trials of novel agents, strategies or standard of care.
  • Developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanisms by which therapies work.
  • Tumor microenvironment signaling related to cancer progression including the immune component.
  • New bioinformatics technologies for analysis of genomic data.

The young investigator part of the team must hold a title of postdoctoral fellow, instructor, research associate, assistant professor or equivalent, and should be within six years of completion of a professional degree or clinical training. She or he should not have received more than $200,000 in current direct research funding, including institutional funds. Young investigators who have received research support from NCI, NIH or DoD are still qualified (and strongly encouraged) to apply.

Application Deadline: April 29, 2016 by 3:00 p.m. EDT. Application Guideline for the award. 

CFR Contact: Brooke Church, Senior Director of Corporate and Foundation Relations for Health Affairs,  or (919) 962-0024.

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone (919) 962-3423. 

Filed under: